
Stocks in Focus on Mar 9: Sun Pharma, TCS, NMDC & More
By Malvika Gurung Investing.com -- Sun Pharmaceuticals (NS:SUN): The drugmaker subsidiary Taro Pharmaceuticals USA has acquired the subsidiary companies of the Swiss pharma company Galderma,...
By Malvika Gurung Investing.com -- Sun Pharmaceuticals (NS:SUN): The drugmaker subsidiary Taro Pharmaceuticals USA has acquired the subsidiary companies of the Swiss pharma company Galderma,...
Mumbai (Maharashtra) [India], February 1 (ANI/NewsVoir): Yasho Industries Limited (BSE: 541167 | ISIN: INE616Z01012) a leading Indian manufacturer & supplier of specialty and fine...
Sales rise 77.23% to Rs 163.81 crore
May 13 (Reuters) - Yasho Industries Ltd YASO.BO :* YASHO INDUSTRIES LTD - RECOMMENDED DIVIDEND OF RS. 0.50 PER SHARE FOR FY 2020-21...
May 12 (Reuters) - Yasho Industries Ltd YASO.BO :* YASHO INDUSTRIES LTD MARCH QUARTER PROFIT 91 MILLION RUPEES VERSUS 23.4 MILLION RUPEES YEAR AGO* YASHO INDUSTRIES LTD MARCH QUARTER...
Feb 9 (Reuters) - Yasho Industries Ltd YASO.BO :* YASHO INDUSTRIES LTD DEC QUARTER PROFIT 94.6 MILLION RUPEES VERSUS 45.7 MILLION RUPEES YEAR AGO* YASHO INDUSTRIES LTD DEC QUARTER REVENUE...
Jan 6 (Reuters) - Yasho Industries Ltd YASO.BO :* CFO VINOD HARILAL JHAVERI RESIGNS* NAMES YAYESH VINOD JHAVERI AS CFO...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.